# Allogene Therapeutics Inc. (ALLO) — Net Income

## Annual Net Income (USD)

| Year | Net Income |
| --- | --- |
| 2025 | -$191M |
| 2024 | -$258M |
| 2023 | -$327M |
| 2022 | -$340M |
| 2021 | -$182M |
| 2020 | -$316M |
| 2019 | -$185M |

## Quarterly Net Income (USD)

| Quarter | Net Income |
| --- | --- |
| 2025-09-30 | -$41M |
| 2025-06-30 | -$51M |
| 2025-03-31 | -$60M |
| 2024-09-30 | -$66M |
| 2024-06-30 | -$66M |
| 2024-03-31 | -$65M |
| 2023-09-30 | -$62M |
| 2023-06-30 | -$79M |
| 2023-03-31 | -$100M |
| 2022-09-30 | -$83M |
| 2022-06-30 | -$75M |
| 2022-03-31 | -$80M |
| 2021-09-30 | -$78M |
| 2021-06-30 | -$71M |
| 2021-03-31 | -$33M |
| 2020-09-30 | -$66M |
| 2020-06-30 | -$61M |
| 2020-03-31 | -$54M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ALLO/net-income)